BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

469 related articles for article (PubMed ID: 28745689)

  • 21. Platelet to lymphocyte ratio is associated with the current activity of ANCA-associated vasculitis at diagnosis: a retrospective monocentric study.
    Park HJ; Jung SM; Song JJ; Park YB; Lee SW
    Rheumatol Int; 2018 Oct; 38(10):1865-1871. PubMed ID: 30088046
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comprehensive Analysis of Sex Differences at Disease Manifestation in ANCA-Associated Glomerulonephritis.
    Tampe D; Korsten P; Ströbel P; Hakroush S; Tampe B
    Front Immunol; 2021; 12():736638. PubMed ID: 34630417
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The level of urinary α1 microglobulin excretion is a useful marker of peritubular capillaritis in antineutrophil cytoplasmic antibody associated vasculitis.
    Ohashi N; Ishigaki S; Kitajima K; Tsuji N; Isobe S; Iwakura T; Ono M; Fujikura T; Tsuji T; Sakao Y; Kato A; Yasuda H
    Clin Exp Nephrol; 2015 Oct; 19(5):851-8. PubMed ID: 25528655
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Urinary Soluble CD163 and Disease Activity in Biopsy-Proven ANCA-Associated Glomerulonephritis.
    Aendekerk JP; Timmermans SAMEG; Busch MH; Potjewijd J; Heeringa P; Damoiseaux JGMC; Reutelingsperger CP; van Paassen P;
    Clin J Am Soc Nephrol; 2020 Dec; 15(12):1740-1748. PubMed ID: 33203735
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-mobility group box-1 protein (HMGB1) is increased in antineutrophilic cytoplasmatic antibody (ANCA)-associated vasculitis with renal manifestations.
    Bruchfeld A; Wendt M; Bratt J; Qureshi AR; Chavan S; Tracey KJ; Palmblad K; Gunnarsson I
    Mol Med; 2011; 17(1-2):29-35. PubMed ID: 20844833
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum levels of 12 renal function and injury markers in patients with glomerulonephritis.
    Serwin NM; Wiśniewska M; Jesionowska A; Skwirczyńska E; Marcinowska Z; Dołęgowska B
    Pol Arch Med Wewn; 2016 Aug; 126(7-8):483-93. PubMed ID: 27511639
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of MPO-ANCA-mediated oxidative imbalance on renal vasculitis.
    Hilhorst M; Maria AT; Kavian N; Batteux F; Borderie D; Le Quellec A; van Paassen P; Guilpain P
    Am J Physiol Renal Physiol; 2018 Dec; 315(6):F1769-F1776. PubMed ID: 30207165
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Circulating neutrophil gelatinase-associated lipocalin: a useful biomarker for assessing disease activity of ANCA-associated vasculitis.
    Chen M; Wang F; Zhao MH
    Rheumatology (Oxford); 2009 Apr; 48(4):355-8. PubMed ID: 19181656
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-ETAR and suPAR as markers of disease activity in renal ANCA-associated vasculitis.
    Rowaiye OO; Kusztal M; Zabinska M; Bartoszek D; Myszka M; Kościelska-Kasprzak K; Banasik M; Mazanowska O; Klinger M; Krajewska M
    Adv Med Sci; 2022 Mar; 67(1):23-28. PubMed ID: 34781174
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Microparticles expressing myeloperoxidase as potential biomarkers in anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitides (AAV).
    Manojlovic M; Juto A; Jonasdottir A; Colic J; Vojinovic J; Nordin A; Bruchfeld A; Gunnarsson I; Mobarrez F; Antovic A
    J Mol Med (Berl); 2020 Sep; 98(9):1279-1286. PubMed ID: 32734361
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum soluble programmed cell death protein 1 could predict the current activity and severity of antineutrophil cytoplasmic antibody-associated vasculitis: a monocentric prospective study.
    Yoon T; Ahn SS; Jung SM; Song JJ; Park YB; Lee SW
    Clin Exp Rheumatol; 2019; 37 Suppl 117(2):116-121. PubMed ID: 30873951
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High anti-neutrophil cytoplasmic antibody titers are associated with the requirement of permanent dialysis in patients with myeloperoxidase-ANCA-associated vasculitis.
    Yen CL; Tian YC; Wu HH; Tu KH; Liu SH; Lee CC; Fang JT; Yang CW; Li YJ
    J Formos Med Assoc; 2019 Oct; 118(10):1408-1415. PubMed ID: 31133523
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Composite urinary biomarkers to predict pathological tubulointerstitial lesions in lupus nephritis.
    Ding Y; Nie LM; Pang Y; Wu WJ; Tan Y; Yu F; Zhao MH
    Lupus; 2018 Oct; 27(11):1778-1789. PubMed ID: 30020021
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antineutrophil cytoplasmic antibody negative pauci-immune extracapillary glomerulonephritis.
    Villacorta J; Diaz-Crespo F; Acevedo M; Guerrero C; Mollejo M; Fernandez-Juarez G
    Nephrology (Carlton); 2016 Apr; 21(4):301-7. PubMed ID: 26369898
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The significances of peripheral neutrophils CD(55) and myeloperoxidase expression in patients with myeloperoxidase-specific anti-neutrophil cytoplasmic antibody associated vasculitis].
    Zhou XL; Zheng MJ; Shuai ZW; Zhang L; Zhang MM; Chen SY
    Zhonghua Nei Ke Za Zhi; 2017 Jun; 56(6):427-432. PubMed ID: 28592042
    [No Abstract]   [Full Text] [Related]  

  • 36. Propylthiouracil-induced antineutrophil cytoplasmic antibody (ANCA)-associated renal vasculitis versus primary ANCA-associated renal vasculitis: a comparative study.
    Chen YX; Zhang W; Chen XN; Yu HJ; Ni LY; Xu J; Pan XX; Ren H; Chen N
    J Rheumatol; 2012 Mar; 39(3):558-63. PubMed ID: 22247359
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Two types of myeloperoxidase-antineutrophil cytoplasmic autoantibodies with a high affinity and a low affinity in small vessel vasculitis.
    Yoshida M; Sasaki M; Nakabayashi I; Akashi M; Tomiyasu T; Yoshikawa N; Kojima T; Ohno N; Yamada M
    Clin Exp Rheumatol; 2009; 27(1 Suppl 52):S28-32. PubMed ID: 19646343
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rheumatoid factor is correlated with disease activity and inflammatory markers in antineutrophil cytoplasmic antibody-associated vasculitis.
    Watanabe S; Gono T; Nishina K; Sugitani N; Watanabe E; Yabe H; Terai C
    BMC Immunol; 2017 Dec; 18(1):53. PubMed ID: 29262790
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of a novel chemiluminescence enzyme immunoassay (CLEIA) with enzyme-linked immunosorbent assay (ELISA) for the determination of MPO-ANCA in patients with ANCA-associated vasculitis.
    Hirose O; Itabashi M; Takei T; Nitta K
    Mod Rheumatol; 2015 Mar; 25(2):230-4. PubMed ID: 25388618
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of circulating level of high mobility group box 1 with disease activity in antineutrophil cytoplasmic autoantibody-associated vasculitis.
    Wang C; Gou SJ; Chang DY; Yu F; Zhao MH; Chen M
    Arthritis Care Res (Hoboken); 2013 Nov; 65(11):1828-34. PubMed ID: 24591411
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.